Multicenter, cross-sectional study of the economic burden of multiple sclerosis and cost-driving factors

Expert Review of Pharmacoeconomics & Outcomes Research

This study highlights MS's economic burden in Algeria, with DMTs as the primary cost driver. Optimized resource allocation and cost-effective DMT strategies are essential to improve MS care.

Authors: Moustafa Berrichi, Zahira Barka-Bedrane, Ahlam Osmani, Karima Belahcen, Bouchra Hafsi, Ines Messaoudi, Mohammed Adil Selka, Houari Toumi

DOI: https://doi.org/10.1080/14737167.2025.2539840

Publish Year: 2025